Partial
Partially Aligned
Patient Risk:
Moderate
Summary
Most organ-system immune-mediated adverse reaction assertions are supported by the provided label excerpt (5.1). However, multiple symptom and definition-style claims (e.g., diarrhea/abdominal pain/fatigue for colitis; jaundice/fatigue/abdominal pain for hepatitis; nausea for hypophysitis; itching/swelling/rash for dermatitis; cough/SOB/fatigue for pneumonitis; explicit “inflammation of X” definitions) are not supported in the provided label text, creating material gaps in accuracy.
Category Scores
Accurate Statements
Yervoy (ipilimumab) can cause severe immune-mediated adverse reactions (IMRs).
5.1: “Immune-mediated adverse reactions, which may be severe or fatal, can occur…”
Yervoy can cause immune-mediated adverse reactions that can affect the skin.
5.1: “Immune-Mediated Dermatologic Adverse Reactions… YERVOY can cause immune-mediated rash or dermatitis…”
Yervoy can cause immune-mediated adverse reactions that can affect the liver.
5.1: “Immune-Mediated Hepatitis… Immune-mediated hepatitis occurred…”
Yervoy can cause immune-mediated adverse reactions that can affect the kidneys.
5.1: “Immune-Mediated Nephritis with Renal Dysfunction… occurred…”
Yervoy can cause immune-mediated adverse reactions that can affect the thyroid.
5.1: Immune-Mediated Endocrinopathies including hypothyroidism, thyroiditis, hyperthyroidism.
Yervoy can cause immune-mediated adverse reactions that can affect the lungs.
5.1: “Immune-Mediated Pneumonitis… Immune-mediated pneumonitis occurred…”
Yervoy can cause immune-mediated colitis.
5.1: “Immune-Mediated Colitis… YERVOY can cause immune-mediated colitis, which may be fatal.”
Yervoy can cause immune-mediated hepatitis.
5.1: “Immune-Mediated Hepatitis… Immune-mediated hepatitis occurred…”
Yervoy can cause hypophysitis.
5.1: “YERVOY can cause immune-mediated hypophysitis… Hypophysitis occurred…”
Hypophysitis can affect hormone production.
5.1: “Hypophysitis can cause hypopituitarism. Initiate hormone replacement as clinically indicated.”
Hypophysitis can cause headache.
5.1: “Hypophysitis can present with… such as headache…”
Yervoy can cause dermatitis.
5.1: “YERVOY can cause immune-mediated rash or dermatitis…”
Yervoy can cause pneumonitis.
5.1: “Immune-Mediated Pneumonitis… Immune-mediated pneumonitis occurred…”
Unsupported Statements
Yervoy (ipilimumab) is a medication used to treat certain types of cancer, including melanoma and kidney cancer.
The provided excerpt does not include the formal indication statement from 1 INDICATIONS AND USAGE. The excerpt mentions RCC (kidney cancer) and melanoma within 5.1, but the overall treatment/indication wording is not provided.
Immune-mediated colitis is inflammation of the colon.
The provided label excerpt does not define colitis as “inflammation of the colon.”
Immune-mediated colitis can cause diarrhea.
No symptom of diarrhea is mentioned in the provided colitis excerpt.
Immune-mediated colitis can cause abdominal pain.
No symptom of abdominal pain is mentioned in the provided colitis excerpt.
Immune-mediated colitis can cause fatigue.
No symptom of fatigue is mentioned in the provided colitis excerpt.
Immune-mediated hepatitis is inflammation of the liver.
The provided excerpt does not explicitly define hepatitis as “inflammation of the liver.”
Immune-mediated hepatitis can cause fatigue.
No symptom of fatigue is mentioned in the provided hepatitis excerpt.
Immune-mediated hepatitis can cause jaundice.
No symptom of jaundice is mentioned in the provided hepatitis excerpt.
Immune-mediated hepatitis can cause abdominal pain.
No symptom of abdominal pain is mentioned in the provided hepatitis excerpt.
Hypophysitis can cause nausea.
Nausea is not mentioned in the provided hypophysitis excerpt.
Dermatitis is skin inflammation.
The provided excerpt mentions dermatitis but does not define it as “skin inflammation.”
Dermatitis can cause rash.
The excerpt lists “rash or dermatitis” as immune-mediated reactions, but does not state that dermatitis causes rash.
Dermatitis can cause itching.
Itching is not mentioned in the provided dermatologic excerpt.
Dermatitis can cause swelling.
Swelling is not mentioned in the provided dermatologic excerpt.
Pneumonitis is inflammation of the lungs.
The provided excerpt does not explicitly define pneumonitis as “inflammation of the lungs.”
Pneumonitis can cause cough.
Cough is not mentioned in the provided pneumonitis excerpt.
Pneumonitis can cause shortness of breath.
Shortness of breath is not mentioned in the provided pneumonitis excerpt.
Pneumonitis can cause fatigue.
Fatigue is not mentioned in the provided pneumonitis excerpt.
Contradictions
Important Omissions
Specific monitoring recommendations were not mentioned (e.g., baseline and before each dose evaluation of liver enzymes, creatinine, ACTH, and thyroid function; consider prompt medical management).
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Moderate
While major immune-mediated adverse reaction categories align with the label excerpt, multiple symptom-level claims are unsupported in the provided text; additionally, key monitoring/management guidance present in 5.1 was omitted, which could reduce labeling accuracy for safe use.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Medium |
Recommendation
Partially Aligned
Primary Issue
Numerous symptom/definition assertions are not supported by the provided label excerpt (5.1). Indication wording is only partially supported because the formal indications section text is not included in the excerpt.
Suggested Improvement
Remove or revise unsupported symptom and definition claims (e.g., diarrhea/abdominal pain/fatigue for colitis; jaundice/fatigue/abdominal pain for hepatitis; nausea for hypophysitis; itching/swelling/rash causality for dermatitis; cough/SOB/fatigue for pneumonitis). Limit adverse reaction descriptions to those explicitly stated in the excerpt, and incorporate the label’s monitoring recommendations (baseline and before each dose labs/ACTH/thyroid, prompt evaluation/management).